Detalhe da pesquisa
1.
Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum.
Nat Genet
; 39(3): 366-72, 2007 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17322883
2.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Mult Scler
; 21(7): 953-5, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25305253
3.
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
Glia
; 62(10): 1645-58, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24910450
4.
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.
N Engl J Med
; 365(14): 1293-303, 2011 Oct 06.
Artigo
Inglês
| MEDLINE | ID: mdl-21991951
5.
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Mult Scler
; 20(6): 705-16, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24126064
6.
Multiple sclerosis registries in Europe - results of a systematic survey.
Mult Scler
; 20(11): 1523-32, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24777278
7.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Lancet
; 380(9856): 1829-39, 2012 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-23122650
8.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Lancet
; 380(9856): 1819-28, 2012 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-23122652
9.
Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
Mult Scler
; 19(12): 1618-26, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23462348
10.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Mult Scler
; 19(10): 1310-9, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23447359
11.
A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia.
PLoS Biol
; 8(6): e1000408, 2010 Jun 29.
Artigo
Inglês
| MEDLINE | ID: mdl-20613862
12.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
J Neurol Neurosurg Psychiatry
; 83(8): 796-802, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22693287
13.
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years.
Mult Scler
; 18(9): 1278-89, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22307384
14.
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
Mult Scler
; 18(11): 1625-32, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22723573
15.
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
Brain
; 134(Pt 3): 693-703, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21354972
16.
[New therapies in multiple sclerosis]. / Actualités thérapeutiques dans la sclérose en plaques.
Rev Prat
; 62(8): 1057-60, 2012 Oct.
Artigo
Francês
| MEDLINE | ID: mdl-23227596
17.
Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords.
Ann Neurol
; 68(4): 465-76, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20687208
18.
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
Brain
; 133(9): 2578-91, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20688809
19.
Geographic variations of multiple sclerosis in France.
Brain
; 133(Pt 7): 1889-99, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20551111
20.
Natural history of multiple sclerosis with childhood onset.
N Engl J Med
; 356(25): 2603-13, 2007 Jun 21.
Artigo
Inglês
| MEDLINE | ID: mdl-17582070